Search Results for 'cab hiv'

cab hiv published presentations and documents on DocSlides.

CAB for PrEP for Advocates
CAB for PrEP for Advocates
by hadly
Basics of Injectable Cabotegravir. for HIV Prevent...
The Penn CFAR CAB Welcomes You to the
The Penn CFAR CAB Welcomes You to the
by lois-ondreau
City of Brotherly Love and Sisterly Affection. ...
Long Acting ART for Treatment and
Long Acting ART for Treatment and
by tatyana-admore
PrEP. Anton Pozniak . MD FRCP. Consultant Physici...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by conchita-marotz
, . prodrug. of . temsavir. . (attachment inhib...
New Drugs in Development
New Drugs in Development
by marina-yarberry
New Drugs in Development Are We Ready for Long-Ac...
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
by jade
Madeline Droney, PharmD. In it for the Long-Haul. ...
CONFERENCE ON RETROVIRUSES
CONFERENCE ON RETROVIRUSES
by winnie
AND OPPORTUNISTIC INFECTIONS. CROI 2023. 19-23 FEB...
Cabotegravir plus  Rilpivirine
Cabotegravir plus Rilpivirine
by jaxson809
Extended Release Injectable Suspension. Last Updat...
UK-CAB: 1 May 2020 COVID-19 update
UK-CAB: 1 May 2020 COVID-19 update
by vivian
:. summary of studies from HTB. Simon Collins. www...
IM Cabotegravir and IM  Rilpivirine
IM Cabotegravir and IM Rilpivirine
by brooke
Every 2 Months for HIV Maintenance. . ATLAS-2M. I...
1 University of Nebraska Medical Center, Omaha, NE, United States;
1 University of Nebraska Medical Center, Omaha, NE, United States;
by min-jolicoeur
1 University of Nebraska Medical Center, Omaha, N...
1 Queen Mary University, London, United Kingdom;
1 Queen Mary University, London, United Kingdom;
by trish-goza
1 Queen Mary University, London, United Kingdom; ...
Switch to INSTI   NNRTI Switch to DTG   RPV
Switch to INSTI NNRTI Switch to DTG RPV
by trish-goza
SWORD. . Study. Switch to CAB LA RPV LA IM. LA...
Long-Acting Injectables
Long-Acting Injectables
by calandra-battersby
for PrEP. Sinead Delany-Moretlwe. University of t...
Switch to INSTI + NNRTI
Switch to INSTI + NNRTI
by giovanna-bartolotta
Switch to DTG + RPV. SWORD. . Study. Switch to C...
Ruling Out HIV Infection
Ruling Out HIV Infection
by adah
Clinical training for providers. March 2023. Train...
HIV Prevention England Conference
HIV Prevention England Conference
by felicity
18 February 2020. -. A two-stage randomised phase ...
Community
Community
by yoshiko-marsland
Mobilization . in HIV Vaccine Research. UZ-UCSF A...
UK Community Advisory Board (UK-CAB)
UK Community Advisory Board (UK-CAB)
by kittie-lecroy
HIV treatment advocates network. Introduction to ...
ART for Prevention… What Happens Next?
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
What’s New & Next in
What’s New & Next in
by badra
HIV Prevention . Mitchell Warren. July 2021. Outli...
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Challenging Cases in Antiretroviral Therapy and Panel Discussion
by gagnon
Paul E. Sax, MD. Professor of Medicine. Harvard Me...
CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI 2020)
CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI 2020)
by miguel
AND OPPORTUNISTIC INFECTIONS. (CROI 2020). BOSTON|...
Safety , Tolerability, and Pharmacokinetics of Long-Acting Injectable
Safety , Tolerability, and Pharmacokinetics of Long-Acting Injectable
by phoebe-click
Cabotegravir. in Low-Risk . HIV-uninfected . Wom...
Community Engagement in the
Community Engagement in the
by InLoveWithLife
PopART. Study. Musonda Simwinga. Pre- study engag...